Mometasone Nasal Spray (Mometasone Furoate)

Adult use

For allergic rhinitis: Typically, spray 2 times in each nostril once daily (total daily dose of 0.2 mg). Once symptoms are relieved, the maintenance dose can be reduced to 1 spray in each nostril (total daily dose of 0.1 mg). If symptoms are not relieved, up to 4 sprays can be administered in each nostril once daily (total daily dose of 0.4 mg). For nasal polyps: Typically, spray 2 times in each nostril once daily.

Child use

For allergic rhinitis: Typically, spray 1 time in each nostril once daily (total daily dose of 0.1 mg).

This medication is a nasal corticosteroid used to treat allergic rhinitis or inflammation in the nasal cavity. It should not be used in certain patients. For example, if there is an allergy to this medication or any of its components, if there is an untreated infection in the nasal mucosa, if the patient has had recent nasal surgery or trauma, and it should not be administered to infants under 2 years of age. Additionally, it requires special caution in patients with respiratory tuberculosis or systemic infections, recurrent nosebleeds, a risk of chickenpox or measles infection, and in pregnant or breastfeeding women, as the risks and benefits need to be carefully considered. While using this medication, side effects such as headache, nosebleeds, cough, upper respiratory infections, and pharyngitis may occur, and in rare cases, serious hypersensitivity reactions such as allergic responses, bronchospasm, and difficulty breathing may be observed. If such symptoms appear, the medication should be discontinued immediately and medical attention sought. Prolonged high-dose use may lead to systemic corticosteroid side effects, so caution is advised, and regular check-ups are recommended to monitor changes in the nasal mucosa. Particularly in children, there is a possibility of growth delay, so growth status should be monitored regularly during treatment. This medication may interact with other drugs, especially if the patient is taking CYP3A4 inhibitors, which may increase the risk of systemic side effects. Pregnant or breastfeeding women need to carefully weigh the potential risks and benefits of using this medication and monitor its effects on the fetus or infant. When using, shake the container well, spray only in the nasal cavity, and be careful not to spray directly into the eyes or nasal septum. Keep out of reach of children, and safely discard after the specified period of use. Finally, this medication may yield positive results in doping tests for athletes, so caution is advised.

Serious side effects

Hives, severe swelling (edema), chest tightness, shortness of breath, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with fever indicating respiratory issues, yellowing skin or eyes (jaundice), severe fatigue, sudden and very severe headache, thunderclap headache, seizures, confusion, vision disturbances, paralysis, urination issues.

Mild side effects

Headache, viral infections, pharyngitis, nosebleeds/bloody mucus, cough, upper respiratory infections, menstrual discomfort, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, ear pain, cold symptoms, muscle pain, nausea, rhinitis, inflammation of the nose, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), symptoms of pharyngitis (irritation, discomfort).

This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is important to maintain a storage temperature between 2 degrees and 25 degrees Celsius, avoiding extremes of heat or cold. This will help preserve the effectiveness of the medication.

Appearance

An opaque suspension that is white or nearly white in a container that dispenses a specific amount.

Package unit

18g/bottle